ResMed Inc. RMD
Set alert
232.94 USD +3.00 +1.30%
At close
232.94 0.00 0.00%
Pre-market · Nov 3, 5:31 AM ET
227.73 Day range 233.76
180.27 52-week range 277.67
- YTD
- -3.29%
- 1 year
- -5.65%
- Open
- 231.27
- Prev close
- 229.94
- Mkt cap
- 32.76B
- Vol
- 1.60M
- Avg vol
- 1.35M
- EPS
- 10.98
- P/E
- 21.21
- Div yield
- 1.04%
More statistics
- Low
- 227.73
- High
- 233.76
- Forward P/E
- 17.59
- Beta
- 0.76
- Short ratio
- 10.34
- Inst. own
- 73.22%
- Dividend
- 2.64
- Ex-div date
- Nov 11, 2026
- Earnings
- Jan 28, 2027
- 50-d avg
- 231.80
- 200-d avg
- 224.88
- 1y target
- 265.11
MAX chart
Events in this range
- Apr 3, 2000Split: 2 for 1
- Oct 3, 2005Split: 2 for 1
- Sep 5, 2012Dividend: 0.17
- Feb 7, 2017Dividend: 0.33
- Feb 7, 2018Dividend: 0.35
- Nov 7, 2018Dividend: 0.37
- Feb 6, 2019Dividend: 0.37
- Feb 7, 2019Dividend: 0.37
- Nov 6, 2019Dividend: 0.39
- Nov 7, 2019Dividend: 0.39
- Feb 7, 2024Dividend: 0.48
- Nov 7, 2024Dividend: 0.53
- Aug 6, 2026Earnings: 2.95; estimate 2.89; surprise 2.08%
- Nov 2, 2026Downgrade: Canaccord Genuity · Buy → Hold
Signals (144)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 1, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | May 1, 2024 | 2 years ago |
| SMA: Bullish | Apr 1, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 1, 2024 | 2 years ago |
Newest 20 of 144.
Analyst view
Consensus: buy
Buy
Price target (mean) 265.11 +13.8% upside
Now 232.94
- Target (low)
- 210.00
- Target (mean)
- 265.11
- Target (high)
- 320.00
Ratings (0m) 20 9 buy · 10 hold · 1 sell
- Strong buy2
- Buy7
- Hold10
- Sell1
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 20
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.98 | 2.93 – 3.06 | 2.81 | +6.2% | 1.46B | +2.4% | 13 |
| Next quarter | 3.07 | 3.02 – 3.17 | 2.86 | +7.2% | 1.46B | +1.8% | 13 |
| Current year | 12.12 | 11.82 – 12.23 | 11.17 | +8.5% | 5.83B | +3.2% | 20 |
| Next year | 13.24 | 12.78 – 13.73 | 12.12 | +9.2% | 6.20B | +6.3% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Canaccord Genuity | Downgrade | Buy | Hold |
| Oct 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Sep 15, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Aug 31, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Rothschild & Co | Initiated | — | Neutral |
| Aug 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 7, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 7, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Jul 10, 2026 | Jefferies | Maintained | Hold | Hold |
| Jul 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 22, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jun 17, 2026 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 15, 2026 | Citigroup | Maintained | Buy | Buy |
| May 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Apr 9, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 30, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 30, 2026 | Stifel | Maintained | Hold | Hold |
| Dec 18, 2025 | Stifel | Maintained | Hold | Hold |